Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injury through a multistage continuous targeted strategy

Efficient delivery of antioxidant drugs into mitochondria of ischemic cardiomyocytes where reactive oxygen species largely induced is a major challenge for precise treatment of myocardial ischemia–reperfusion injury. Herein, we report a smart dual-shell polymeric nanoparticle, MCTD-NPs, which utiliz...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine 2019-02, Vol.16, p.236-249
Main Authors: Cheng, Ying, Liu, Dao-zhou, Zhang, Chang-xiong, Cui, Han, Liu, Miao, Zhang, Bang-le, Mei, Qi-bing, Lu, Zi-fan, Zhou, Si-yuan
Format: Article
Language:English
Subjects:
Mitochondria-targeted
Mitochondrial reactive oxygen species
Myocardial ischemia/reperfusion injury
Precise treatment
Resveratrol
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efficient delivery of antioxidant drugs into mitochondria of ischemic cardiomyocytes where reactive oxygen species largely induced is a major challenge for precise treatment of myocardial ischemia–reperfusion injury. Herein, we report a smart dual-shell polymeric nanoparticle, MCTD-NPs, which utilizes multistage continuous targeted strategy to deliver reactive oxygen species scavenger specifically to mitochondria of ischemic cardiomyocytes upon systemic administration. In vitro experiments indicated that the intracellular uptake of MCTD-NPs was specifically enhanced in hypoxia reoxygenation injured H9c2 cells. MCTD-NPs selectively delivered resveratrol to mitochondria of hypoxia reoxygenation injured H9c2 cells. In addition, MCTD-NPs increased the viability of H/R injured H9c2 cell through eliminating mitochondrial ROS, decreasing mPTP opening and blocking mitochondria-dependent apoptotic pathway. In vivo experiments revealed that MCTD-NPs increased the distribution of resveratrol in the ischemic myocardium and subsequently reduced infarct size in MI/RI rats. These results demonstrated a novel platform for specific delivery of antioxidant to mitochondria to treat MI/RI. Resveratrol was targeted to mitochondria through a multistage continuous targeted strategy for precise treatment of myocardial ischemia–reperfusion injury, the mitochondria-targeted resveratrol could scavenge the ROS in ischemic cardiomyocyte and inhibit the apoptosis of damaged cardiomyocyte. [Display omitted]
ISSN:1549-9634
1549-9642
DOI:10.1016/j.nano.2018.12.014